N-(tert-Butoxycarbonyl)-N-methyl-D-allo-isoleucine is a chiral, N-methylated, and Boc-protected derivative of the non-proteinogenic amino acid D-allo-isoleucine. It serves as a specialized building block in the synthesis of modified peptides and peptidomimetics. The tert-butoxycarbonyl (Boc) group is a standard protecting group for amines in solid-phase peptide synthesis (SPPS), particularly in Boc-SPPS strategies. Its primary application is in medicinal chemistry and peptide research for the construction of peptides with enhanced metabolic stability, altered conformational properties, and improved bioavailability. The incorporation of N-methyl amino acids, such as this derivative, is a key strategy to reduce peptide backbone hydrogen bonding, increase membrane permeability, and confer resistance to proteolytic degradation. This makes it valuable for developing peptide-based therapeutics, including constrained peptides and macrocycles. This compound is a high-purity, research-grade chemical used by pharmaceutical and biotechnology companies, as well as academic laboratories, engaged in advanced peptide drug discovery programs. It is typically handled under standard laboratory safety protocols for organic compounds.